A deadly spillover: SARS-CoV-2 outbreak.
作者信息
Mori Mattia, Capasso Clemente, Carta Fabrizio, Donald William A, Supuran Claudiu T
机构信息
Department of Biotechnology, Chemistry and Pharmacy, Department of Excellence 2018-2022, University of Siena , Siena, Italy.
Department of Biology, Agriculture and Food Sciences, CNR, Institute of Biosciences and Bioresources, CNR , Napoli, Italy.
出版信息
Expert Opin Ther Pat. 2020 Jul;30(7):481-485. doi: 10.1080/13543776.2020.1760838. Epub 2020 Apr 29.
Abstract
摘要
相似文献
1
A deadly spillover: SARS-CoV-2 outbreak.一场致命的溢出事件：新冠病毒疫情
Expert Opin Ther Pat. 2020 Jul;30(7):481-485. doi: 10.1080/13543776.2020.1760838. Epub 2020 Apr 29.
2
China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response.中国对新型冠状病毒的应对与 2002 年 SARS 疫情的应对形成鲜明对比。
Nat Med. 2020 Mar;26(3):310-311. doi: 10.1038/s41591-020-0771-1.
3
A hundred days into the coronavirus disease (COVID-19) pandemic.新型冠状病毒肺炎（COVID-19）疫情爆发一百天之际。
Euro Surveill. 2020 Apr;25(14). doi: 10.2807/1560-7917.ES.2020.25.14.2000550.
4
Perspective on the COVID-19 Coronavirus Outbreak.关于新冠病毒疫情的观点。
Comb Chem High Throughput Screen. 2020;23(2):90-91. doi: 10.2174/138620732302200406130010.
5
The SARS-CoV-2 outbreak: What we know.新型冠状病毒爆发：我们所知道的。
Int J Infect Dis. 2020 May;94:44-48. doi: 10.1016/j.ijid.2020.03.004. Epub 2020 Mar 12.
6
China Coronavirus Outbreak: All the Latest Updates.中国新冠疫情：所有最新消息。
Curr Top Med Chem. 2020;20(8):601-602. doi: 10.2174/1568026620999200305144537.
7
COVID-19 Outbreak: An Overview on Dentistry.COVID-19 疫情爆发：牙科综述。
Int J Environ Res Public Health. 2020 Mar 22;17(6):2094. doi: 10.3390/ijerph17062094.
8
The Wuhan SARS-CoV-2-What's next for China.武汉的新冠病毒——中国的下一步是什么。
J Med Virol. 2020 Jun;92(6):546-547. doi: 10.1002/jmv.25738. Epub 2020 Mar 18.
9
An outbreak of COVID-19 caused by a new coronavirus: what we know so far.由新型冠状病毒引起的COVID-19疫情：我们目前所了解的情况。
Med J Aust. 2020 May;212(9):393-394.e1. doi: 10.5694/mja2.50530. Epub 2020 Mar 8.
10
Open access epidemiological data from the COVID-19 outbreak.来自新冠疫情的开放获取流行病学数据。
Lancet Infect Dis. 2020 May;20(5):534. doi: 10.1016/S1473-3099(20)30119-5. Epub 2020 Feb 19.
引用本文的文献
1
Assessment of the Risk Impact of SARS-CoV-2 Infection Prevalence between Cats and Dogs in America and Europe: A Systematic Review and Meta-Analysis.美国和欧洲猫与狗之间感染 SARS-CoV-2 流行率的风险影响评估：一项系统综述和荟萃分析
Pathogens. 2024 Apr 12;13(4):314. doi: 10.3390/pathogens13040314.
2
Leveraging SARS-CoV-2 Main Protease (M) for COVID-19 Mitigation with Selenium-Based Inhibitors.利用 SARS-CoV-2 主要蛋白酶（M）与基于硒的抑制剂减轻 COVID-19。
Int J Mol Sci. 2024 Jan 12;25(2):971. doi: 10.3390/ijms25020971.
3
Exploration of phenolic acid derivatives as inhibitors of SARS-CoV-2 main protease and receptor binding domain: potential candidates for anti-SARS-CoV-2 therapy.探索酚酸衍生物作为新型冠状病毒主要蛋白酶和受体结合域的抑制剂：抗新型冠状病毒治疗的潜在候选物
Front Chem. 2023 Sep 26;11:1251529. doi: 10.3389/fchem.2023.1251529. eCollection 2023.
4
Identification of sulphonamide-tethered -((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease.鉴定磺胺键合-((三唑-4-基)甲基)色酮衍生物作为 SARS-CoV-2 主蛋白酶抑制剂。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2234665. doi: 10.1080/14756366.2023.2234665.
5
SARS-CoV-2 in Namibian Dogs.纳米比亚犬体内的严重急性呼吸综合征冠状病毒2型
Vaccines (Basel). 2022 Dec 13;10(12):2134. doi: 10.3390/vaccines10122134.
6
Genome Similarities between Human-Derived and Mink-Derived SARS-CoV-2 Make Mink a Potential Reservoir of the Virus.源自人类和水貂的新冠病毒之间的基因组相似性使水貂成为该病毒的潜在宿主。
Vaccines (Basel). 2022 Aug 19;10(8):1352. doi: 10.3390/vaccines10081352.
7
Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection?碳酸酐酶抑制作用是否可作为 COVID-19 感染的辅助治疗方法？
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1230-1235. doi: 10.1080/14756366.2021.1924165.
8
Therapeutic approaches for SARS-CoV-2 infection.针对 SARS-CoV-2 感染的治疗方法。
Methods. 2021 Nov;195:29-43. doi: 10.1016/j.ymeth.2021.04.026. Epub 2021 May 5.
9
Updated and Validated Pan-Coronavirus PCR Assay to Detect All Coronavirus Genera.更新和验证的泛冠状病毒 PCR 检测方法可检测所有冠状病毒属。
Viruses. 2021 Apr 1;13(4):599. doi: 10.3390/v13040599.
10
Interactions between SARS coronavirus 2 papain-like protease and immune system: A potential drug target for the treatment of COVID-19.严重急性呼吸综合征冠状病毒 2 型木瓜蛋白酶样蛋白酶与免疫系统的相互作用：COVID-19 治疗的潜在药物靶点。
Scand J Immunol. 2021 Oct;94(4):e13044. doi: 10.1111/sji.13044. Epub 2021 Aug 10.
本文引用的文献
1
Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.撤回说明：严重急性呼吸综合征冠状病毒2通过其刺突蛋白介导的膜融合感染T淋巴细胞。
Cell Mol Immunol. 2020 Aug;17(8):894. doi: 10.1038/s41423-020-0498-4.
2
Structure of M from SARS-CoV-2 and discovery of its inhibitors.SARS-CoV-2 M 结构与抑制剂的发现
Nature. 2020 Jun;582(7811):289-293. doi: 10.1038/s41586-020-2223-y. Epub 2020 Apr 9.
3
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses.针对新兴致病性人类冠状病毒的亚单位疫苗
Front Microbiol. 2020 Feb 28;11:298. doi: 10.3389/fmicb.2020.00298. eCollection 2020.
4
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.强效泛冠状病毒融合抑制剂抑制 SARS-CoV-2（前称 2019-nCoV）感染，该抑制剂针对病毒的刺突蛋白，具有很强的介导膜融合能力。
Cell Res. 2020 Apr;30(4):343-355. doi: 10.1038/s41422-020-0305-x. Epub 2020 Mar 30.
5
Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures.2019冠状病毒病：夸大信息和非循证措施的危害
Eur J Clin Invest. 2020 Mar 23:e13223. doi: 10.1111/eci.13223.
6
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.SARS-CoV-2 主蛋白酶的晶体结构为设计改良的 α-酮酰胺抑制剂提供了基础。
Science. 2020 Apr 24;368(6489):409-412. doi: 10.1126/science.abb3405. Epub 2020 Mar 20.
7
Remdesivir as a possible therapeutic option for the COVID-19.瑞德西韦作为治疗新冠肺炎的一种可能选择。
Travel Med Infect Dis. 2020 Mar-Apr;34:101615. doi: 10.1016/j.tmaid.2020.101615. Epub 2020 Mar 5.
8
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).2019新型冠状病毒（2019-nCoV）的治疗选择。
Nat Rev Drug Discov. 2020 Mar;19(3):149-150. doi: 10.1038/d41573-020-00016-0.
9
Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.SARS-CoV-2 的进化史、潜在的中间宿主动物及种间分析。
J Med Virol. 2020 Jun;92(6):602-611. doi: 10.1002/jmv.25731. Epub 2020 Mar 11.
10
A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option.洛匹那韦疗法治疗严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒的系统评价——为新型冠状病毒病治疗方案提供参考。
J Med Virol. 2020 Jun;92(6):556-563. doi: 10.1002/jmv.25729. Epub 2020 Mar 12.
Zotero 插件